Filing Details

Accession Number:
0001232524-14-000067
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-06-26 20:21:12
Reporting Period:
2014-06-24
Filing Date:
2014-06-26
Accepted Time:
2014-06-26 20:21:12
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1232524 Jazz Pharmaceuticals Plc JAZZ Pharmaceutical Preparations (2834) 981032470
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1536639 Seamus Mulligan 45 Fitzwilliam Square
Dublin 2 L2
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares Disposition 2014-06-24 4,199 $147.08 1,451,356 No 4 S Direct
Ordinary Shares Disposition 2014-06-24 15,742 $148.13 1,435,614 No 4 S Direct
Ordinary Shares Disposition 2014-06-24 7,772 $149.17 1,427,842 No 4 S Direct
Ordinary Shares Disposition 2014-06-24 8,896 $150.19 1,418,946 No 4 S Direct
Ordinary Shares Disposition 2014-06-24 4,000 $151.36 1,414,946 No 4 S Direct
Ordinary Shares Disposition 2014-06-24 4,500 $152.10 1,410,446 No 4 S Direct
Ordinary Shares Disposition 2014-06-24 3,800 $153.06 1,406,646 No 4 S Direct
Ordinary Shares Disposition 2014-06-24 1,044 $154.54 1,405,602 No 4 S Direct
Ordinary Shares Disposition 2014-06-25 47 $148.64 1,405,555 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $146.74 to $147.53, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
  3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $147.74 to $148.73, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
  4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $148.74 to $149.73, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
  5. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $149.74 to $150.73, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
  6. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $150.78 to $151.76, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
  7. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $151.79 to $152.73, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
  8. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $152.82 to $153.65, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
  9. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $154.41 to $154.85, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.